SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-285210
Filing Date
2023-11-29
Accepted
2023-11-29 16:30:58
Documents
1
Group Members
BLACKSTONE CLARUS III L.L.C.BLACKSTONE GROUP MANAGEMENT L.L.C.BLACKSTONE HOLDINGS I/II GP L.L.C.BLACKSTONE INC.CLARUS LIFESCIENCES III, L.P.CLARUS VENTURES III GP, L.P.STEPHEN A. SCHWARZMAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d605126dsc13da.htm SC 13D/A 155965
  Complete submission text file 0001193125-23-285210.txt   157840
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Subject) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86491 | Film No.: 231452647
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BLACKSTONE INC. 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O BLACKSTONE INC. 345 PARK AVENUE NEW YORK NY 10154 212-583-5000
Blackstone Holdings II L.P. (Filed by) CIK: 0001484870 (see all company filings)

IRS No.: 260288604
Type: SC 13D/A